NCT06483308View on ClinicalTrials.gov

Shortened High-dose Palliative Radiotherapy for Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 27, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Stage IV Lung Cancer
Interventions
RADIATION

Radiotherapy

Radiotherapy using 30Gy in 6 fractions (alternate days) over 12 days.

Trial Locations (4)

ST4 6QG

NOT_YET_RECRUITING

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent

CV2 2DX

RECRUITING

University Hospitals Coventry and Warwickshire, Coventry

B15 2

NOT_YET_RECRUITING

University Hospitals Birmingham NHS Foundation Trust, Birmingham

SY2 6LG

RECRUITING

The Shrewsbury and Telford Hospital NHS Trust, Shrewsbury

All Listed Sponsors
lead

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

NCT06483308 - Shortened High-dose Palliative Radiotherapy for Lung Cancer | Biotech Hunter | Biotech Hunter